UBE2C and neoplasm: The results demonstrated that the UBE2C promoter was hypomethylated in CHOL (Figure 4A), KIRC (Figure 4B), and PCPG (Figure 4C) tumor tissues compared to corresponding normal tissues (p < 0.01).